Found: 9
Select item for more details and to access through your institution.
PAX2 Expression in Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 3, p. 6090, doi. 10.3390/ijms14036090
- By:
- Publication type:
- Article
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1875, doi. 10.1038/s41416-024-02668-w
- By:
- Publication type:
- Article
Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133<sup>+</sup> Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma.
- Published in:
- Stem Cells, 2008, v. 26, n. 6, p. 1414, doi. 10.1634/stemcells.2007-1009
- By:
- Publication type:
- Article
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
- Published in:
- Journal of Pathology, 2013, v. 231, n. 4, p. 449, doi. 10.1002/path.4252
- By:
- Publication type:
- Article
Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS<sup>G12D</sup> or KRAS<sup>G12V</sup> mutations.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77666-y
- By:
- Publication type:
- Article
Allelic imbalance analysis by high‐density single‐nucleotide polymorphic allele (SNP) array with whole genome amplified DNA.
- Published in:
- Nucleic Acids Research, 2004, v. 32, n. 9, p. e69, doi. 10.1093/nar/gnh072
- By:
- Publication type:
- Article
The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3043, doi. 10.3390/cancers12103043
- By:
- Publication type:
- Article
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03820-x
- By:
- Publication type:
- Article
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135101
- By:
- Publication type:
- Article